Sagis Podiatric Case Review:

Porocarcinoma + Nail Bed BCC in Separate Digits on Same Foot

Case Overview

By Bryan Markinson, DPM
Educational podiatric pathology case review series

Patient: 68-year-old female
Lesion Locations: Right third toe (lateral skin) and right hallux nail bed
Clinical Presentation: Granulating lesion on the lateral third toe of one to two years duration (patient thought it was a blister), and a non-healing, oozing wound on the right hallux nail bed following self-trimming of a thickened, discolored nail. Prior history of squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) at other sites.


A 68-year-old female with a history of multiple cutaneous malignancies was referred for definitive care of a malignant eccrine porocarcinoma of the right third toe, confirmed on prior biopsy by the referring podiatrist. At initial presentation, she also had a non-healing wound on the right hallux nail bed — the result of self-trimming a chronically thickened, detached nail — which had never healed and continued to ooze. Workup for the porocarcinoma included PET/CT (negative for distant metastasis), oncology consultation, and sentinel lymph node (SLN) biopsy planning. Three weeks later, on the day of scheduled surgery, the hallux wound remained unhealed and a nail bed punch biopsy was added to the operative plan.

Take a moment to review the clinical images below to see how Dr. Markinson arrived at these diagnoses.

(Clinical photograph: pre-oped delineating amputation incision and right hallux nail bed lesion, right foot)

(Clinical photograph: non-healing wound, right hallux nail bed)

 

Specimen Overview

Four specimens were submitted at the time of surgery:

  • Specimen A — Third digit, right toe (suture placed lateral, caudal to original biopsy site)
  • Specimen B — Right hallux nail bed punch biopsy
  • Specimen C — Right inguinal sentinel lymph node #1 (300 mg)
  • Specimen D — Right inguinal sentinel lymph node #2 (180 mg)

 

Key Histologic Findings

Specimen A — Porocarcinoma, Third Toe

Histologic examination of the amputated third digit confirmed:

  • Residual porocarcinoma with free surgical margins
  • No lymphovascular invasion
  • No perineural invasion
  • Correlation with prior biopsy (RP-26-0084) confirmed on multiple sections

 

Specimen B — Basal Cell Carcinoma, Nail Bed

The nail bed punch biopsy revealed:

  • Basal cell carcinoma, nodular type
  • Nests of basaloid cells with peripheral palisading
  • Retraction artifact between tumor islands and stroma
  • No significant cytologic atypia beyond that expected for BCC

 

Specimens C & D — Sentinel Lymph Nodes

  • Specimen C: One benign lymph node — no evidence of malignancy (0/1)
  • Specimen D: One benign lymph node — no evidence of malignancy (0/1)

 

Differential Diagnosis: Three Common Mimickers

When evaluating non-healing or granulating lesions of the nail unit and digit, several diagnoses must be considered. The three most important mimickers are outlined below.

1️⃣  Subungual Melanoma

Etiology: Malignant transformation of subungual melanocytes; accounts for a disproportionate share of melanoma in darker-skinned populations

Histology:

  • Atypical melanocytes along the nail matrix and bed epithelium
  • Pagetoid spread of melanocytes into the overlying epithelium
  • Variable melanin pigmentation; may be amelanotic
  • Longitudinal melanonychia in clinical presentation

 

Key Distinction: Subungual melanoma typically presents with longitudinal melanonychia and demonstrates pagetoid spread on histology — neither of which is a feature of nail bed BCC. Immunohistochemistry (S-100, SOX10, Melan-A) can confirm melanocytic process.

 

2️⃣  Subungual Squamous Cell Carcinoma

Etiology: Most common malignant tumor of the nail unit; frequently HPV-associated (types 16/18) in this location

Histology:

  • Atypical squamous proliferation with variable differentiation
  • Keratin pearls and individual cell dyskeratosis
  • May show koilocytic change if HPV-related
  • Invasive growth into nail bed dermis

 

Key Distinction: Subungual SCC is the most common nail unit malignancy and shows squamous differentiation with keratin production. HPV in-situ hybridization or p16 immunostaining can help support an HPV-driven etiology.

 

3️⃣  Pyogenic Granuloma / Chronic Granulation Tissue

Etiology: Reactive vascular proliferation, often following minor trauma or nail manipulation; also mimics malignancy clinically

Histology:

  • Lobular capillary proliferation with edematous stroma
  • Inflammatory infiltrate with neutrophils and fibrin
  • No cytologic atypia or malignant architecture
  • Ulceration common on the surface

 

Key Distinction: Pyogenic granuloma and chronic granulation tissue are the most common benign mimickers of nail unit malignancy following trauma — exactly the scenario in this case, where the patient attributed the wound to nail trimming. The absence of cytologic atypia, malignant architecture, and the lobular vascular pattern distinguish these reactive lesions from carcinoma. When healing fails to progress with standard care, biopsy is essential.

 

The Final Diagnoses 

  1. Porocarcinoma (Malignant Eccrine Poroma), Third Toe — Residual, Margins Free
  2. Basal Cell Carcinoma, Nodular Type — Right Hallux Nail Bed

Porocarcinoma is a rare malignancy of eccrine sweat gland origin characterized by ductal and poroid differentiation, elevated mitotic activity, and meaningful metastatic potential. Nail bed BCC — while histologically identical to BCC elsewhere — is exceptionally rare in the toe, making this a coincidental dual occurrence in the same foot. Both diagnoses were confirmed in the setting of negative sentinel lymph nodes, supporting localized disease at the time of excision.

 

Key Takeaways:

  • Porocarcinoma is a rare sweat gland malignancy with metastatic potential — sentinel lymph node biopsy is appropriate for staging.
  • BCC of the nail unit (especially the toe) is extremely rare; any non-healing nail bed wound without a clear traumatic or infectious explanation warrants biopsy.
  • A prior history of cutaneous malignancy should always elevate clinical suspicion when new lesions appear — this patient’s history of SCC and BCC elsewhere was a critical context clue.
  • Patient-reported delay in seeking evaluation must be documented; from a risk management perspective, this is pivotal in cases where delay in diagnosis is alleged.
  • When healing does not progress in a timely manner with standard of care, or if a clinician series has attempted treatment, immediate biopsy is indicated.

 

📚 Quick Summary

Feature Porocarcinoma Nail Bed BCC Subungual Melanoma Subungual SCC
Origin Eccrine sweat glands Basal cell layer Melanocytes Squamous epithelium
Nail unit occurrence ❌ Rare ❌ Extremely rare ✅ Classic site ✅ Common but likely underestimated due to misdiagnosis
Metastatic potential ✅ Yes ❌ Rare ✅ High ✅ Moderate to low
Key histologic clue Ductal/poroid cells, high mitoses Peripheral palisading, retraction artifact Malignant melanocytes Keratin pearls, dyskeratosis
Longitudinal melanonychia ❌ No ⚠️ Sometimes ✅ 30% of cases preceded by longitudinal melanonychia ❌ No
Behavior Aggressive Locally aggressive Slow growing Locally aggressive

 

💬 Final Thought

Synchronous rare malignancies in the same foot (porocarcinoma of the toe and BCC of the nail bed) serve as a powerful reminder that any non-healing lesion demands histologic confirmation. When the clinical story doesn’t add up, the microscope tells the truth.

 

Sagis Podiatric Pathology is proud to support dermatology residents and dermatology residency programs through high-quality educational content and learning resources.

Follow us on Instagram for more micro-learning opportunities with interactive cases and podiatric pathology insights.

Related Case Reviews

Join Our Dermpath Educational Community

Access expert-led content, and stay in the loop on upcoming sessions and resources from our Dermpath Educational community.

Presented by

Bryan Markinson, DPM

Did you know we are diagnostics lab?

Sagis Podiatry delivers accurate, timely diagnoses with dedicated support from our lab team and direct access to our pathologists.